Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Research and Development

- PMLiVE

Ipsen to acquire worldwide rights to pre-clinical stage oncology programme

The company has an existing partnership with the Université de Montréal and IRICoR

- PMLiVE

Ipsen reports positive phase 3 data for Onivyde in pancreatic cancer

The investigational treatment regimen met its primary endpoint of overall survival

- PMLiVE

Ipsen to acquire rare disease specialist Albireo in deal worth over $950m

The deal will strengthen the biopharma’s liver disease pipeline with the addition of Bylvay

- PMLiVE

Ipsen’s cabozantinib receives NICE approval for advanced hepatocellular carcinoma

The treatment showed a significant improvement in overall survival versus placebo

- PMLiVE

UK Government announces £50m research boost to tackle health inequalities

The investment will be given to 13 local authorities across the UK, from Aberdeen to Plymouth

Patient Centric Approaches for Rare and Ultra-Rare Diseases

Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shares how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale....

Impetus Digital

- PMLiVE

Merck KGaA announces launch of start-up collaboration programme in Asia

The selected companies will receive up to €100,000 in financial assistance, as well as mentoring from Merck

- PMLiVE

Moderna to launch Innovation and Technology Center in the UK

With support from the UK government, the manufacturing facility is expected to produce up to 250 million doses annually

- PMLiVE

Genomics England will move headquarters to Canary Wharf’s new life sciences hub

The company will join the growing number of healthcare and life sciences-focused organisations currently located in Canary Wharf

- PMLiVE

AstraZeneca unveils plans for new US R&D centre

The site, scheduled for completion in 2026, will also include the headquarters of Alexion

- PMLiVE

Virtual Science AI introduces new advisory platform

The platform offers the life sciences industry a new tool for online interactions with HCPs, patient communities and decision-makers

- PMLiVE

Novartis restructures organisation to support growth and innovation

The new operational structure will involve integrating pharmaceuticals and oncology business units into an Innovative Medicines business

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links